← Leaderboards
Michele Follen
University Of Texas Md Anderson Can Ctr
$1,788,996
Attributed
$1,788,996
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$30,463,801 · 6
By mechanism
P01$30,438,801 · 4
R13$25,000 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Karen Hsieh Lu$10,934,889
- Diane Bodurka$2,204,406
- Scott B. Cantor$1,543,894
- Calum E Macaulay$1,150,861
- Karen M Basen-Engquist$10,237,208
Others in their field
Top investigators on “Optics”
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$425,121,299
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Francis L Halzen · University Of Wisconsin-Madison$212,820,462
- Ethan Schreier · Associated Universities, Inc.$206,468,864
- Demian A Bailey · Oregon State University$205,233,456
- Clare E Reimers · Gordon Research Conferences$205,233,456
Research focus
OpticsMortality Vital StatisticsResourcesTechnologyMalignant Neoplasm Of Cervix UteriCervicalCancer EtiologyCostProgramsResearch InfrastructureMolecular ImagingBaseWomanClinical Research SiteClinical TrialsCollegeTrainingDiagnosisUnited StatesImageEmerging TechnologiesNeoplasm /Cancer DiagnosisLesionNeoplasms
Grant awards (26)
Optical Technologies and Molecular Imaging for Cervical Neoplasia$2,266,232
P01 · FY2014 · CA · contact PI
Clinical Effectiveness$183,417
P01 · FY2014 · CA · contact PI
Administration and Protocol Management$58,575
P01 · FY2014 · CA · contact PI
Optical Technologies and Molecular Imaging for Cervical Neoplasia$2,374,167
P01 · FY2013 · CA · contact PI
Clinical Effectiveness$199,512
P01 · FY2013 · CA · contact PI
Administration and Protocol Management$88,410
P01 · FY2013 · CA · contact PI
Optical Technologies and Molecular Imaging for Cervical Neoplasia$2,469,576
P01 · FY2012 · CA · contact PI
Clinical Effectiveness$179,600
P01 · FY2012 · CA · contact PI
Administration and Protocol Management$137,841
P01 · FY2012 · CA · contact PI
Optical Technologies and Molecular Imaging for Cervical Neoplasia$2,431,163
P01 · FY2011 · CA · contact PI
Administration and Protocol Management$186,474
P01 · FY2011 · CA · contact PI
Clinical Effectiveness$133,136
P01 · FY2011 · CA · contact PI
Optical Technologies and Molecular Imaging for Cervical Neoplasia$2,451,402
P01 · FY2010 · CA · contact PI
Administration and Protocol Management$158,350
P01 · FY2010 · CA · contact PI
Clinical Effectiveness$133,434
P01 · FY2010 · CA · contact PI
Optical Technologies for Cervical Neoplasia$2,437,591
P01 · FY2007 · CA · contact PI
Optical Technologies for Cervical Neoplasia$2,437,346
P01 · FY2006 · CA · contact PI
Optical Technologies for Cervical Neoplasia$2,423,378
P01 · FY2005 · CA
Optical Technologies for Cervical Neoplasia$2,357,097
P01 · FY2004 · CA
Optical Technologies for Cervical Neoplasia$3,071,804
P01 · FY2003 · CA
2nd International Cervical Cancer Conference$5,000
R13 · FY2002 · CA
FLUORESCENCE SPECTROSCOPY FOR CERVICAL NEOPLASIA$2,048,936
P01 · FY2001 · CA
Conference on Optics for Biotechnology$20,000
R13 · FY2001 · CA
Core--Instrumentation$0
P01 · FY2001 · CA
FLUORESCENCE SPECTROSCOPY FOR CERVICAL NEOPLASIA$1,906,113
P01 · FY2000 · CA
Core--Instrumentation$305,247
P01 · FY2000 · CA